Skip to main content

Program Management

Schedules

TAFS: 075-0511 /X - Program Management

Iterations:
Adjustment authority: Yes
Reporting categories: No
Line #SplitDescriptionIteration 5
Previously Approved Amount
Iteration 6
Current OMB Action Amount
Footnotes
1000DADiscretionary Actual- Unob Bal: Brought forward, October 1$106,151,121 $106,151,121
1000MAMandatory Actual - Unob Bal: Brought forward, October 1$6,816,096,403 $6,816,096,403
1200BA: Mand: Appropriation$121,000,000 $121,000,000
1700BA: Disc: Spending auth: Collected$17,811,213+$3,044,406
$20,855,619
1740BA: Disc: Spending auth:Antic colls, reimbs, other$12,988,787-$3,044,406
$9,944,381
1800BA: Mand: Spending auth: Collected$1,178,187,472+$211,860,027
$1,390,047,499
1801BA: Mand: Spending auth: Chng uncoll pymts Fed src$198,354,461-$157,290,517
$41,063,944
1802BA: Mand: Spending auth: Previously unavailable$115,059,560 $115,059,560
1823BA: Mand: Spending auth: New\Unob bal temp reduced-$81,625,124 -$81,625,124
1840BA: Mand: Spending auth:Antic colls, reimbs, other$333,487,940-$54,569,510
$278,918,430
1920Total budgetary resources avail (disc. and mand.)$8,817,511,833 $8,817,511,833
6001Category A -- 1st quarter$77,783,221 $77,783,221
6002Category A -- 2nd quarter$70,838,058 $70,838,058
6003Category A -- 3rd quarter$127,070,293 $127,070,293
6004Category A -- 4th quarter$60,551,824 $60,551,824
6013Extending the Independence at Home Medical Practice Demonstration Program (Sec 105, P.L. 116-260)$4,000,000 $4,000,000
6019Provider Enrollment Fees (ACA 6401, P.L.111-148)$67,692,526 $67,692,526
6022Nursing Home CMPs (ACA 6111, P.L.111-148)$13,101,662 $13,101,662
6023RAC Retention Fees (MACRA 505, P.L.114-10)$26,984,823 $26,984,823
6024SHIPS (Consolidated Appropriations Act Sec. 103, P.L. 116-260)$16,826,979 $16,826,979
6026Clinical Diagnostic Laboratory Test (PAMA 216, P.L.113-93)$3,690,000 $3,690,000
6028Ensuring Accurate Valuation of Services (PAMA 220, P.L.113-93)$2,600,000 $2,600,000
6038Open Payments CMPs (ACA 6002, P.L.111-148)$3,460,816 $3,460,816
6042Medicare Ambulance Services (BBA 50203, P.L.115-123)$1,614,749 $1,614,749
6044Recovery Audit Contractors - Part A/B (Section 302, P.L.109-432)$154,355,000 $154,355,000
6046Recovery Audit Contractors - MSP (Section 302, P.L.109-432)$70,855,128 $70,855,128
6048Marketplace User Fees (Section 1311&1321, P.L.111-148)$2,282,428,972 $2,282,428,972
6049Risk Adjustment User Fees (Section 1343, P.L.111-148)$67,111,111 $67,111,111
6050Extension of Funding for Quality Measure (Consolidated Appropriations Act Sec. 102, P.L. 116-260)$25,182,681 $25,182,681
6051Expanding the Use of Telehealth Services (SUPPORT 2001, P.L.115-271)$362,135 $362,135
6053Grants to Provide Technical Assistance to Outlier Prescribers (SUPPORT 6052, P.L.115-271)$2,884,342+$572,125
$3,456,467
6055Recovery Audit Contractors - Part D (Section 302, P.L. 109-432)$500,000 $500,000
6057Repeal Medicare Payment Cap Therapy Services (BBA 50202)$5,000,000 $5,000,000
6058Beneficiary Enrollment Simplification (Consolidated Appropriations Act Sec. 120, P.L. 116-260)$700,000 $700,000
6059Implementation Funding (Consolidated Appropriations Act Sec. 501, P.L. 116-260)$14,170,000 $14,170,000
6062Medicare Payment for Rural Emergency Hospital Services (Consolidated Appropriations Act Sec. 125, P.$6,879,579 $6,879,579
6063Establishing Hospice Program Survey and Enforcement Procedures Under the Medicare Program (CAA 407)$9,445,000 $9,445,000
6064Independent Dispute Resolution User Fees (No Surprises Act Sec. 103, 105, 112, P.L. 116-260)$800,000 $800,000
6065Postal Service Reform Act of 2022 (H.R. 3076)$7,500,000 $7,500,000
6066Lowering Prices through Drug Price Negotiation Implementation (Inflation Reduction Act Sec. 11004, H$105,420,000 $105,420,000
6067Part B Price Inflation Rebate Implementation (Inflation Reduction Act Sec. 11101, H.R. 5376)$16,802,952 $16,802,952
6068Part D Price Inflation Rebate Implementation (Inflation Reduction Act Sec. 11102, H.R. 5376)$9,810,000 $9,810,000
6069Part D Redesign Implementation (Inflation Reduction Act Sec. 11201, H.R. 5376)$39,700,000 $39,700,000
6071Part D Cost Sharing Implementation (Inflation Reduction Act Sec. 11202, H.R. 5376)$10,000,000 $10,000,000
6072Health Services in School Settings / Technical Assistance Center (BSCA Section 11003, P.L. 117-159)$6,000,000 $6,000,000
6073NSA Plan and Issuer Enforcement CMPs Part A Collections (ACA Sec 104 & 106, P.L. 111-148)$589,375 $589,375
6074NSA Plan and Issuer Enforcement CMPs Part D Collections (ACA Sec 104 & 106, P.L. 111-148)$589,375 $589,375
6075Early and Periodic Screening, Diagnosis, and Treatment Benefit - Guidance and Reporting (BSCA Sec. 1$2,275,922 $2,275,922
6076Skilled Nursing Facility Value-Based Purchasing (CAA Sec. 111, P.L. 116-260)$3,260,000 $3,260,000
6077Advancing Telehealth Beyond COVID-19 (Consolidated Appropriations Act, 2023, H.R.2617)$10,000,000 $10,000,000
6078Improvements to Medicare Prospective Payment System for Psychiatric Hospitals and Psychiatric Units$10,000,000 $10,000,000
6079Extension of Acute Hospital Care at Home (Consolidated Appropriations Act, 2023, H.R.2617)$5,000,000 $5,000,000
6080Waiver of Cap on Annual Payments for Nursing and Allied Health Education Payments (Consolidated Appr$3,000,000 $3,000,000
6081Supporting Access to a Continuum of Crisis Response Services Under Medicaid and CHIP (Consolidated A$8,000,000 $8,000,000
61701Apportioned in FY 2024 and future fiscal years - Category A$232,197,550 $232,197,550
617010Apportioned in FY 2024 and future fiscal years - RAC Retention Fees (MACRA 505, P.L.114-10)$271,111,105 $271,111,105
617011Apportioned in FY 2024 and future fiscal years - Value-Based Purchasing Program for SNFs (PAMA 215,$2,428,409 $2,428,409
617012Apportioned in FY 2024 and future fiscal years - Clinical Diagnostic Laboratory Test (PAMA 216, P.L.$2,566,121 $2,566,121
617013Apportioned in FY 2024 and future fiscal years - Ensuring Accurate Valuation of Services (PAMA 220,$4,098,372 $4,098,372
617014Apportioned in FY 2024 and future fiscal years - Post-Acute Care Common Measurement Tool (IMPACT 2a,$2,534,866 $2,534,866
617015Apportioned in FY 2024 and future fiscal years - Assessment and Analysis on Adjustments (IMPACT 2d2D$654,078 $654,078
617016Apportioned in FY 2024 and future fiscal years - Repealing SGR and Improving Medicare Payments (MACR$10,771,880 $10,771,880
617017Apportioned in FY 2024 and future fiscal years - Open Payments CMPs (ACA 6002, P.L.111-148)$504,849 $504,849
617018Apportioned in FY 2024 and future fiscal years - Prohibition of Inclusion of SSNs (MACRA 501, P.L.11$11,487,808 $11,487,808
617019Apportioned in FY 2024 and future fiscal years - Treatment of Cancer Hospitals (CURES 16002, P.L.114$1,968,433 $1,968,433
61702Apportioned in FY 2024 and future fiscal years - Extending the Independence at Home Medical Practice$3,385,156 $3,385,156
617020Apportioned in FY 2024 and future fiscal years - Medicare Site-of-Service (CURES 4011, P.L.114-255)$256,414 $256,414
617021Apportioned in FY 2024 and future fiscal years - Recovery Audit Contractors - Part A/B (Section 302,$714,451,153 $714,451,153
617022Apportioned in FY 2024 and future fiscal years - Recovery Audit Contractors - MSP (Section 302, P.L.$646,557,498 $646,557,498
617023Apportioned in FY 2024 and future fiscal years - Marketplace User Fees (Section 1311&1321, P.L.111-1$233,258,945 $233,258,945
617024Apportioned in FY 2024 and future fiscal years - Risk Adjustment User Fees (Section 1343, P.L.111-14$76,237,657 $76,237,657
617025Apportioned in FY 2024 and future fiscal years - Extension of Funding for Quality Measure (Consolida$2,766,029 $2,766,029
617026Apportioned in FY 2024 and future fiscal years - Grants to Provide Technical Assistance to Outlier P$63,644,176-$572,125
$63,072,051
617027Apportioned in FY 2024 and future fiscal years - Recovery Audit Contractors - Part D (Section 302, P$500,000 $500,000
617028Apportioned in FY 2024 and future fiscal years - Quality Incentives Computed Tomography (PAMA 218, P$14,518,320 $14,518,320
617029Apportioned in FY 2024 and future fiscal years - Repeal Medicare Payment Cap Therapy Services (BBA 5$21,219,719 $21,219,719
61703Apportioned in FY 2024 and future fiscal years - Diagnostic Lab Tests (ACA 3113, P.L. 111-148)$1,250,595 $1,250,595
617030Apportioned in FY 2024 and future fiscal years - Beneficiary Enrollment Simplification (Consolidated$4,539,896 $4,539,896
617031Apportioned in FY 2024 and future fiscal years - Implementation Funding (Consolidated Appropriations$1,091,717 $1,091,717
617032Apportioned in FY 2024 and future fiscal years - Establishing Hospice Program Survey and Enforcement$3,866,761 $3,866,761
617033Apportioned in FY 2024 and future fiscal years - Lowering Prices through Drug Price Negotiation Impl$2,892,877,727 $2,892,877,727
617035Apportioned in FY 2024 and future fiscal years - Part D Price Inflation Rebate Implementation (Infla$10,190,000 $10,190,000
617036Apportioned in FY 2024 and future fiscal years - Part D Redesign Implementation (Inflation Reduction$41,573,625 $41,573,625
617037Apportioned in FY 2024 and future fiscal years - Skilled Nursing Facility Value-Based Purchasing (CA$1,455,000 $1,455,000
617038Apportioned in FY 2024 and future fiscal years - Health Services in School Settings / Technical Assi$2,000,000 $2,000,000
617039Apportioned in FY 2024 and future fiscal years - Early and Periodic Screening, Diagnosis, and Treatm$2,724,078 $2,724,078
61704Apportioned in FY 2024 and future fiscal years - Community Prevention (ACA 4202, P.L. 111-148)$37,978,007 $37,978,007
61705Apportioned in FY 2024 and future fiscal years - GNE Demonstration (ACA 5509, P.L.111-148)$14,033,780 $14,033,780
61706Apportioned in FY 2024 and future fiscal years - Medicare and Medicaid Extenders Act of 2010 (Sectio$9,771,441 $9,771,441
61707Apportioned in FY 2024 and future fiscal years - Provider Enrollment Fees (ACA 6401, P.L.111-148)$23,333,945 $23,333,945
61708Apportioned in FY 2024 and future fiscal years - Medicaid Regulations Study and Report (Section 7001$2,854,052 $2,854,052
61709Apportioned in FY 2024 and future fiscal years - Nursing Home CMPs (ACA 6111, P.L.111-148)$96,016,148 $96,016,148
6190Total budgetary resources available$8,817,511,833 $8,817,511,833See footnotes below
Footnotes for line 6190 (Previous):

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

A2: Adjustments are permitted between a Category C line and the corresponding Category B line for that appropriation where OMB receives a revised spend plan, or written notification if no spend plan is customarily provided for that line, 5 business days in advance of obligation and where the total of any adjustments does not increase the receiving Category B line by more than 10% of the previously apportioned amount. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Footnotes for line 6190 (Current):

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

A2: Adjustments are permitted between a Category C line and the corresponding Category B line for that appropriation where OMB receives a revised spend plan, or written notification if no spend plan is customarily provided for that line, 5 business days in advance of obligation and where the total of any adjustments does not increase the receiving Category B line by more than 10% of the previously apportioned amount. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
A2
Adjustments are permitted between a Category C line and the corresponding Category B line for that appropriation where OMB receives a revised spend plan, or written notification if no spend plan is customarily provided for that line, 5 business days in advance of obligation and where the total of any adjustments does not increase the receiving Category B line by more than 10% of the previously apportioned amount. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
A2
Adjustments are permitted between a Category C line and the corresponding Category B line for that appropriation where OMB receives a revised spend plan, or written notification if no spend plan is customarily provided for that line, 5 business days in advance of obligation and where the total of any adjustments does not increase the receiving Category B line by more than 10% of the previously apportioned amount. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.